Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Bytes to Blood—Artificial Intelligence in the Management of Leukemia
0
Zitationen
6
Autoren
2026
Jahr
Abstract
As artificial intelligence (AI) has been proposed to aid in the clinical management of leukemia, we sought to summarize the most relevant, current literature concerning this topic. PubMed was indexed from January 2022 to November 2025 using the search terms "artificial intelligence" AND "leukemia," and 55 papers were deemed relevant and included in this review. We determined AI to be of clinical utility in 3 major areas of leukemia management: detection, risk stratification/treatment planning, and relapse surveillance/management. The application of AI in leukemia management is largely limited to diagnosis-the use of AI in leukemia risk stratification and treatment planning, and relapse detection is largely unexplored. AI has great potential to improve aspects of leukemia management. However, it is currently underutilized and primarily focused on initial diagnosis. The real power of AI lies in optimizing treatment intensity to reduce toxicity and the likelihood of relapse.
Ähnliche Arbeiten
A method of comparing the areas under receiver operating characteristic curves derived from the same cases.
1983 · 7.062 Zit.
Artificial neural networks: a tutorial
1996 · 4.916 Zit.
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
2018 · 4.543 Zit.
Ridge-Based Vessel Segmentation in Color Images of the Retina
2004 · 4.067 Zit.
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 · 3.273 Zit.